Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model

被引:33
作者
Zhang, Hua [1 ]
Kusunose, Jiro [1 ]
Kheirolomoom, Azadeh [1 ]
Seo, Jai W. [1 ]
Qi, Jinyi [1 ]
Watson, Katherine D. [1 ]
Lindfors, Heather A. [1 ]
Ruoslahti, Erkki [2 ]
Sutcliffe, Julie L. [1 ]
Ferrara, Katherine W. [1 ]
机构
[1] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA
[2] Univ Calif Santa Barbara, Burnham Inst Med Res, Santa Barbara, CA 93106 USA
关键词
endothelium; heart; liposome; peptides; positron emission tomography (PET); molecular imaging;
D O I
10.1016/j.biomaterials.2007.12.033
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Efficacious delivery of drugs and genes to the heart is an important goal. Here, a radiolabeled peptide-targeted liposome was engineered to bind to the heart, and the biodistribution and pharmacokinetics were determined by dynamic positron emission tomography in the FVB mouse. Efficient targeting occurred only with an exposed ligand and a dense concentration of peptide (6000 peptides/particles). Liposomes targeted with CRPPR or other arginine-rich peptides with an exposed guanidine moiety bound within 100 s after intravenous injection and remained stably bound. With CRPPR-targeted particles, the radioisotope density in the heart averaged 44 +/- 9% injected dose/gram of tissue, more than 30-fold higher than in skeletal muscle. The rapid and efficient targeting of these particles can be exploited in drug and gene delivery systems and with dynamic positron emission tomography provides a model system to optimize targeting of engineered particles. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1976 / 1988
页数:13
相关论文
共 29 条
[1]  
Bao A, 2003, J NUCL MED, V44, P1992
[2]   Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies [J].
Bao, AD ;
Goins, B ;
Klipper, R ;
Negrete, G ;
Phillips, WT .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) :419-425
[3]  
Brissette R, 2006, CURR OPIN DRUG DISC, V9, P363
[4]  
Chan W., 1999, Fmoc solid phase peptide synthesis: a practical approach
[5]   Advanced drug delivery systems that target the vascular endothelium [J].
Ding, BS ;
Dziubla, T ;
Shuvaev, VV ;
Muro, S ;
Muzykantov, VR .
MOLECULAR INTERVENTIONS, 2006, 6 (02) :98-112
[6]   Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature [J].
Gerlag, DM ;
Borges, E ;
Tak, PP ;
Ellerby, HM ;
Bredesen, DE ;
Pasqualini, R ;
Ruoslahti, E ;
Firestein, GS .
ARTHRITIS RESEARCH, 2001, 3 (06) :357-361
[7]   Vascular targeting: Recent advances and therapeutic perspectives [J].
Hajitou, A ;
Pasqualini, R ;
Arap, W .
TRENDS IN CARDIOVASCULAR MEDICINE, 2006, 16 (03) :80-88
[8]   Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells [J].
Kamps, JAAM ;
Morselt, HWM ;
Swart, PJ ;
Meijer, DKF ;
Scherphof, GL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11681-11685
[9]   Three-layer matrix/sample preparation method for MALDI MS analysis of low nanomolar protein samples [J].
Keller, Bernd O. ;
Li, Liang .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2006, 17 (06) :780-785
[10]   Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis [J].
Koning, GA ;
Schiffelers, RM ;
Wauben, MHM ;
Kok, RJ ;
Mastrobattista, E ;
Molema, G ;
ten Hagen, TLM ;
Storm, G .
ARTHRITIS AND RHEUMATISM, 2006, 54 (04) :1198-1208